OUR PATENTS

Patent No. : 4434/CHE/2014
Title: Synthesis of dihydro imdazo [1,2a] pyridines

Patent No. : IN2016 41003486
Title: An Improved process for preparation of highly pure 4-bromo phenyl acetic acid and its Intermediate

SELECTED RESEARCH PUBLICATIONS

  • S.Venkat Rao, K. Naveen Reddy, D. Komali, Sk. Ameer, “Synthesis of biologically active and novel antifungal agents like Substituted hetero Aryl amines of DihydroImidazo [1, 2-a] pyridine derivatives”. Asian. J. Chem., Vol.No.24, No.7, 3203-3205, 2012.

  • S.Venkat Rao, K. Naveen Reddy, Sk. Ameer, and S. Kumaraswamy “The study of base catalyzed synthesis of 2-chloro-5-Fluoro-4-Aminopyrimidine from a biologically active compound 5-fluorouracil”. J. App. Pharm. Sci. Vol.1, N0.7, 124-126, 2011.

  • S.Venkat Rao and K. Naveen reddy, Simultaneous estimation of Sitagliptin and simvastatin in tablet dosage form by a validated RP-HPLC Method published in “International journal of Pharmaceutical Sciences Review and Research” in June 2012.

    • Research

    SRIGEN has novel technologies for few compounds which are not disclosed anywhere and we can consider them as trade secrets.

    Financial performance:

    Our company is running successfullyfrom the inception with augmented margins from year to year, the summary of the financial data enumerated as follows (Rs. In Lakhs)

    We have been financially supported by KVB for a couple of years by way of working capital limits under CGTMSC Scheme, with this support we have achieved the enhanced performance and expecting better support from them in future. Further the projected turnover is Rs.280.00 Lakhs and Rs.425.00 lakhs for the FY 2016-17 & 2017-18 respectively.